Do vitamin K antagonists affect COPD outcomes? New cohort data explore exacerbation and mortality risk compared with DOACs.
A major trial finds the beta blocker bisoprolol neither improves nor worsens outcomes in people with COPD, despite the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results